Class Action Lawsuits Filed for Multiple Companies
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 15 2026
0mins
Source: Globenewswire
- Lufax Shareholder Lawsuit: Shareholders of Lufax Holding Ltd. have filed a class action due to the company's failure to disclose inadequate internal controls and misstated financial results during the period from April 7, 2023, to January 26, 2025, with a lead plaintiff deadline of May 20, 2026.
- Atara Biotherapeutics Lawsuit: Atara Biotherapeutics, Inc. shareholders initiated a lawsuit for the period from May 20, 2024, to January 9, 2026, alleging undisclosed manufacturing issues and clinical trial risks that jeopardized FDA approval prospects, with a lead plaintiff deadline of May 22, 2026.
- Coty Shareholder Class Action: Coty Inc. shareholders have filed a class action due to the company's failure to disclose underperformance in its Consumer Beauty segment and slowing market growth from November 5, 2025, to February 4, 2026, with a lead plaintiff deadline of May 22, 2026.
- Legal Consultation Information: The Law Offices of Frank R. Cruz remind investors who suffered losses during these periods to contact them for legal advice to protect their rights and interests.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy LU?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on LU
About LU
LUFAX HOLDING LTD is a holding company mainly engaged in providing financial services for small and micro enterprises. The Company's core retail credit enablement business includes bank-funded loans, trust-funded loans and consumer finance loans. The Company is also engaged in wealth management and providing access to financial products and services. The Company conducts the business through its subsidiaries.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Lawsuit Background: Lufax (NYSE:LU) is facing a securities class action lawsuit for failing to disclose related-party transactions, representing investors from April 7, 2023, to January 26, 2025, highlighting serious issues regarding the company's transparency and compliance.
- Auditor Change Impact: On January 27, 2025, Lufax announced the removal of PricewaterhouseCoopers as its auditor, resulting in a nearly 14% drop in stock price that day, reflecting strong market concerns about the company's financial transparency.
- Internal Control Deficiencies: The lawsuit alleges that Lufax lacked adequate internal controls and that its financial results were materially misstated, potentially exposing investors to greater financial losses and affecting the company's future financing capabilities.
- Investigation and Compliance Risks: Hagens Berman is investigating whether Lufax intentionally violated accounting rules and disclosure requirements, and if proven, this could have long-term negative implications for the company's reputation and shareholder trust.
See More
- Class Action Initiation: Rosen Law Firm reminds investors who purchased Lufax securities between April 7, 2023, and January 26, 2025, that an important class action lawsuit was filed on May 20, 2026, allowing investors to seek compensation without any out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that Lufax lacked adequate internal controls and materially misstated financial results during the class period, resulting in investor losses when the true details were revealed, highlighting significant governance and transparency issues within the company.
- Law Firm's Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest settlement against a Chinese company, demonstrating its expertise and successful track record, which investors should consider when selecting legal counsel.
- Investor Action Steps: Investors can join the lawsuit by visiting the designated website or calling the toll-free number, and those wishing to serve as lead plaintiffs must file with the court by May 20, 2026, to ensure their representation in the litigation.
See More
- Litigation Timeline: Shareholders of Lufax (NYSE:LU) who purchased shares between April 7, 2023, and January 26, 2025, are encouraged to register for a class action lawsuit, with a deadline of May 20, 2026, indicating potential legal risks that may affect shareholder confidence.
- Allegations Overview: The lawsuit alleges that Lufax issued materially false and misleading statements during the class period, failing to disclose inadequate internal controls and materially misstated financial results, which could lead to investor losses and reflects deficiencies in corporate governance.
- Shareholder Participation: Once registered, shareholders will be enrolled in a portfolio monitoring software to receive status updates throughout the case lifecycle, indicating transparency in legal proceedings and a focus on shareholder rights, potentially enhancing investor engagement.
- Law Firm Credentials: The Gross Law Firm is a nationally recognized class action law firm committed to protecting investor rights, emphasizing the need for companies to adhere to responsible business practices, showcasing the firm's professionalism and dedication to investor advocacy.
See More
- Lawsuit Background: Lufax announced the removal of its auditor on January 27, 2025, due to concerns over undisclosed related-party transactions, triggering a nearly 14% drop in share price that day, indicating severe investor skepticism regarding the company's financial transparency.
- Lack of Financial Controls: The class action alleges that Lufax lacked adequate internal controls and that certain financial results were materially misstated, with investors learning the truth on January 27, 2025, leading to a swift market reaction and a significant decline in investor confidence.
- Complex Transaction Disclosure: On April 23, 2025, Lufax revealed it had engaged in a series of complex transactions as the sole investor in certain trusts from May 2023 to June 2024, involving asset purchases from affiliated entities, further deepening suspicions about its financial reporting.
- Investigation and Consequences: Hagens Berman is investigating whether Lufax intentionally violated accounting rules and disclosure requirements, and if confirmed, this could lead to broader legal liabilities and financial losses, impacting the company's future market performance.
See More
- Class Action Notice: Rosen Law Firm reminds investors who purchased Lufax securities between April 7, 2023, and January 26, 2025, that May 20 is the deadline to apply as lead plaintiff, allowing potential compensation without any out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that Lufax made false and misleading statements during the class period, failing to disclose inadequate internal controls and materially misstated financial results, resulting in investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest settlement against a Chinese company, recovering over $438 million for investors in 2019 alone, highlighting its strong track record in this field.
- How to Participate: Investors can visit the Rosen Law Firm website or call the toll-free number for more information, emphasizing the importance of selecting qualified legal counsel, as no class has been certified yet, allowing investors to choose whether to participate.
See More
- Class Action Filed: Bragar Eagel & Squire has initiated a class action lawsuit against Lufax in the Central District of California, representing investors who purchased Lufax securities between April 7, 2023, and January 26, 2025, highlighting serious concerns over the company's financial transparency.
- Allegation Details: The lawsuit alleges that Lufax lacked adequate internal controls and materially misstated financial results during the class period, resulting in investor losses when the true information was revealed, indicating potential flaws in corporate governance.
- Investor Rights Protection: Investors must apply by May 20, 2026, to be appointed as lead plaintiff in the lawsuit, underscoring the importance of legal proceedings in protecting investor rights and the need for accountability from company management.
- Law Firm Background: Bragar Eagel & Squire is a nationally recognized law firm specializing in shareholder rights and securities litigation, demonstrating its expertise and influence in advocating for investor rights.
See More











